When it comes to the occurrence of brain tumors, everyone has their own ideas as to why it happens. While none of these can exactly be cemented, there is no question that they can occur and research is done in order to figure out more about these intricate growths. However, is it possible that a mutated gene in the body can play into how these tumors are formed as a result? Judging by a recent article on the matter, I believe it to be the case.
According to a report on Science Daily, it seems as though a mutated gene in the body can cause the development of a benign brain tumor that has its share of effects in the long term. On the surface, this is unfortunate news and while the news in question may not be totally positive, there is still a level of potential that can be realized. For example, is it possible that drugs already put to use for tumor types can be applied here? It seems to be that way.
What are some of the details to consider about this mutated gene? It has been given the name of BRAF, which is one that was seen in almost all of the papillary craniopharyngioma samples seen. These are the ones that are more common in adult patients, as opposed to child patients who are more likely to be afflicted by another craniopharyngioma type known as adamantinomatous. This is what can help to make the selection of certain drugs easier and, as a result, possibly expand methods of remedy in the future.
When talking about the craniopharyngiomas, I was surprised to see how impactful they could see, not to mention how prevalent. For those who do not know, a single BRAF gene can drive tumors like these to become as aggressive as they are. The fact that a simple mutation, as opposed to multiple, can drive these tumors is a point that can potentially aid in the study of brain tumors. This may also make it easier to pinpoint more effective remedies, as organizations like Voices against Brain Cancer can vouch for.
As studies are done on a consistent basis, it is important for them to be as focused as possible so that clear results can come about. This should be kept in mind, whether the focus is set on cancer or what have you. It's apparent that there are certain details to consider, especially when you look at one tumor after another. With so many different intricacies to take into account with each of them, pinpointing a single common trait can prove useful for better procedures in the future.
According to a report on Science Daily, it seems as though a mutated gene in the body can cause the development of a benign brain tumor that has its share of effects in the long term. On the surface, this is unfortunate news and while the news in question may not be totally positive, there is still a level of potential that can be realized. For example, is it possible that drugs already put to use for tumor types can be applied here? It seems to be that way.
What are some of the details to consider about this mutated gene? It has been given the name of BRAF, which is one that was seen in almost all of the papillary craniopharyngioma samples seen. These are the ones that are more common in adult patients, as opposed to child patients who are more likely to be afflicted by another craniopharyngioma type known as adamantinomatous. This is what can help to make the selection of certain drugs easier and, as a result, possibly expand methods of remedy in the future.
When talking about the craniopharyngiomas, I was surprised to see how impactful they could see, not to mention how prevalent. For those who do not know, a single BRAF gene can drive tumors like these to become as aggressive as they are. The fact that a simple mutation, as opposed to multiple, can drive these tumors is a point that can potentially aid in the study of brain tumors. This may also make it easier to pinpoint more effective remedies, as organizations like Voices against Brain Cancer can vouch for.
As studies are done on a consistent basis, it is important for them to be as focused as possible so that clear results can come about. This should be kept in mind, whether the focus is set on cancer or what have you. It's apparent that there are certain details to consider, especially when you look at one tumor after another. With so many different intricacies to take into account with each of them, pinpointing a single common trait can prove useful for better procedures in the future.
About the Author:
For further knowledge about brain tumors, kindly visit Voices against Brain Cancer for specifics.
0 comments:
Post a Comment